Therapeutic Drug Monitoring of Conditioning Agents in Pediatric Allogeneic Stem Cell Transplantation; Where do We Stand?

Allogeneic hematopoietic stem cell transplantation (HSCT) is an established curative treatment that has significantly improved clinical outcome of pediatric patients with malignant and non-malignant disorders. This is partly because of the use of safer and more effective combinations of chemo- and s...

Descripción completa

Detalles Bibliográficos
Autores principales: van der Stoep, M. Y. Eileen C., Oostenbrink, Lisa V. E., Bredius, Robbert G. M., Moes, Dirk Jan A. R., Guchelaar, Henk-Jan, Zwaveling, Juliette, Lankester, Arjan C.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2022
Materias:
Pharmacology
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940165/
https://www.ncbi.nlm.nih.gov/pubmed/35330826
http://dx.doi.org/10.3389/fphar.2022.826004

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8940165/
https://www.ncbi.nlm.nih.gov/pubmed/35330826
http://dx.doi.org/10.3389/fphar.2022.826004

Ejemplares similares